HHTM

LEDERACH, PENNSYLVANIA — RemotEAR, a tele-audiology company, announced a partnership this week with hearing equipment manufacturer, Resonance. RemotEAR’s Deviceware® tele-audiology service is now fully compatible with Resonance’s portable line of equipment. The companies worked together to create a module that enables the Resonance devices to be used with RemotEAR’s Deviceware tele-audiology service, which enables hearing care professionals to expand their

Researchers from Massachusetts Institute of Technology (MIT) Media Lab have developed a computer interface device that can transcribe words that the user verbalizes internally but does not actually speak aloud. As Daniel Van Boom from CNET describes it, “When you think a sentence in your head, your brain sends signals to your mouth and jaw. MIT Media Lab’s headset reads

Tinnitus is a highly prevalent condition with approximately 10%–15% of the population reporting the condition, and 1% to 2% of this group reporting burdensome tinnitus that leads to a severe decrease in the quality of life. Another consideration: tinnitus-related health care expenditures, which are mainly incurred out-of-pocket, are estimated to be nearly $2,000 per year for the individual who copes

SOMERSET, NEW JERSEY — Oticon Inc, announced this week a call for nominations for the 2018 Focus on People Awards. The awards, now in their 20th year, honor students, adults, and hearing loss advocates that demonstrate that “hearing loss doesn’t hinder one’s ability to make a difference in the world”.   “Over the past 20 years, we’ve celebrated more than

Technology has enabled us to be connected like never before. With smartphones, we can watch videos, listen to music, and chat with anyone around the world at any time and from anywhere. These developments have significantly transformed the way we live, work, and play. But can all of this connectivity be too much of a good thing? The use of

A federal indictment was unsealed earlier this week, charging Rasko “Ron” Djordjevic and Milija “Mike” Perkovic with health care fraud, conspiracy to commit health care fraud, and aggravated identity theft, U.S. Attorney Matthew Schneider announced. The announcement was made by US Attorney Matthew Schneider, who was joined in the announcement by Special Agent in Charge Timothy Slater, of the FBI’s

WASHINGTON, DC — GT Biopharma Inc., a clinical stage biotech company, announced the Proof-of-Concept clinical trial of its novel drug treatment for motion sickness, GTP-011, is now more than 50% enrolled. According to the announcement, the trial is a single-blind, placebo-controlled, cross-over study. The study’s primary objective will be to demonstrate the efficacy of transdermal GTP-011 on treating the symptoms of

Developed by the HEARing Cooperative Research Centre (CRC) and the National Acoustic Laboratories (NAL), in partnership with Australian consumer advocacy group Choice, reviews of more than 20 high-fidelity earplugs have been compiled into an interactive website. What Plug? features noise-reduction properties of each earplug type, along with aspects like: comfort, sound quality, ease of use and price.   With research showing increased

MILAN, ITALY — One of the world’s largest hearing aid retailers, Amplifon SpA, is reported to be targeting potential retail acquisitions in Germany, France and Canada and announced plans to enter the Chinese market by the end of 2018. The company, which says it holds approximately 10 percent of the global market, has been focused on improving its position as

A recently published study suggests that US physicians are performing cochlear implantation for a number of conditions that are considered “off-label” of the current FDA labeling indications for implantation. The existing FDA indications for cochlear implantation, as pointed out in an article on the study in ENT Today, date back nearly two decades and cover implantation guidelines for adults and